Evidence map›Paper›PMID 28188172›Full record

ArticleGut2018

T-cell repertoires in refractory coeliac disease.

Julia Ritter, Karin Zimmermann, Korinna Jöhrens, Stefanie Mende, Anke Seegebarth, Britta Siegmund, Steffen Hennig, Kremena Todorova, Andreas Rosenwald, Severin Daum and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Gut, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. T cell receptor sequencing in autoimmunity.Journal of life sciences (Westlake Village, Calif.) · 2020
    Article
  9. Article
  10. Review
  11. Circulating CD8Cancer immunology, immunotherapy : CII · 2018
    Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Julia RitterInstitute of Pathology, Charité-University Medicine, Berlin, Germany.
Karin ZimmermannInstitute of Pathology, Charité-University Medicine, Berlin, Germany.
Korinna JöhrensInstitute of Pathology, Charité-University Medicine, Berlin, Germany.
Stefanie MendeInstitute of Pathology, Charité-University Medicine, Berlin, Germany.
Anke SeegebarthInstitute of Pathology, Charité-University Medicine, Berlin, Germany.
Britta SiegmundDepartment of Gastroenterology, Infectious Diseases and Rheumatology, Charité-University Medicine, Berlin, Germany.
Steffen HennigHS Diagnomics GmbH, Berlin, Germany.
Kremena TodorovaCenter for Tumor Medicine, Charité-University Medicine, Berlin, Germany.
Andreas RosenwaldInstitute of Pathology, University of Würzburg, and Comprehensive Cancer Center Mainfranken (CCCMF), Würzburg, Germany.
Severin DaumDepartment of Gastroenterology, Infectious Diseases and Rheumatology, Charité-University Medicine, Berlin, Germany.
Michael HummelInstitute of Pathology, Charité-University Medicine, Berlin, Germany.
Michael SchumannDepartment of Gastroenterology, Infectious Diseases and Rheumatology, Charité-University Medicine, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEComprehensive Cancer Center Mainfranken · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveRefractory coeliac disease (RCD) is a potentially hazardous complication of coeliac disease (CD). In contrast to RCD type I, RCD type II is a precursor entity of enteropathy-associated T-cell lymphoma (EATL), which is associated with clonally expanding T-cells that are also found in the sequentially developing EATL. Using high-throughput sequencing (HTS), we aimed to establish the small-intestinal T-cell repertoire (TCR) in CD and RCD to unravel the role of distinct T-cell clonotypes in RCD pathogenesis.

designDNA extracted from duodenal mucosa specimens of controls (n=9), active coeliacs (n=10), coeliacs on a gluten-free diet (n=9), RCD type I (n=8), RCD type II (n=8) and unclassified Marsh I cases (n=3) collected from 2002 to 2013 was examined by TCRβ-complementarity-determining regions 3 (CDR3) multiplex PCR followed by HTS of the amplicons.

resultsOn average, 10

conclusionsTCRβ-HTS analysis unravels the TCR in CD and allows detailed analysis of individual TCRβ rearrangements. Dominant TCRβ sequences identified in patients with RCD type II are unique and not homologous to known gliadin-specific TCR sequences, supporting the assumption that these clonal T-cells expand independent of gluten stimulation.

Indexed as

AdultAgedAged, 80 and overBiomarkersCase-Control StudiesCeliac DiseaseDiagnosis, DifferentialDiet, Gluten-FreeDuodenumFemaleGenes, T-Cell Receptor betaHumansImmunosuppressive AgentsIntestinal MucosaIntestine, SmallMaleBiomarkersImmunosuppressive AgentsCOELIAC DISEASELYMPHOMAMOLECULAR PATHOLOGYSMALL INTESTINET-CELL RECEPTOR

Identifiers

PMID28188172
PMCPMC5868243
OpenAlexW2586168232

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.